Novartis' Zelnorm Approved For Chronic Constipation Without Gender Restrictions
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves the supplemental indication despite an advisory committee recommendation that tegaserod use be limited to women. The agency follows the committee's recommendation on use only in individuals under age 65.